Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 683.00
Bid: 683.00
Ask: 683.20
Change: 6.20 (0.92%)
Spread: 0.20 (0.029%)
Open: 685.00
High: 687.80
Low: 679.50
Prev. Close: 676.80
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report - 26 of 54

20 Mar 2015 16:40

RNS Number : 0766I
HSBC Holdings PLC
20 March 2015
 



Credit risk

Page

App

Tables

Page

Credit risk

129

206

Summary of credit risk

129

Gross loans to customers and banks over five years

130

Loan impairment charge over five years

130

Loan impairment charges by geographical region

130

Loan impairment charges by industry

130

Loan impairment allowances over five years

130

Credit risk management

206

Credit exposure

130

Maximum exposure to credit risk

130

Other credit risk mitigants

130

Maximum exposure to credit risk

131

Loan and other credit-related commitments

131

Concentration of exposure

132

206

Financial investments

132

Trading assets

132

Derivatives

132

Loans and advances

132

Gross loans and advances to customers by industry sector and by geographical region

132

Credit quality of financial instruments

133

207

Credit quality classification

Distribution of financial instruments by credit quality

134

Past due but not impaired gross financial instruments

136

Past due but not impaired gross financial instruments by geographical region

136

Ageing analysis of days for past due but not impairedgross financial instruments

136

Impaired loans

137

Movement in impaired loans by geographical region

137

Renegotiated loans and forbearance

138

208

Renegotiated loans and advances to customers bygeographical region

139

Movement in renegotiated loans by geographical region

140

Impairment of loans and advances

141

Loan impairment charge to the income statement by industry sector

141

Loan impairment charge to the income statement by assessment type

141

Charge for impairment losses as a percentage of average gross loans and advances to customers by geographical region

142

Movement in impairment allowances by industry sector and geographical region

142

Movement in impairment allowances on loans and advances to customers and banks

143

Impairment assessment

212

Wholesale lending

144

Total wholesale lending

144

Commercial real estate

145

Commercial real estate lending

145

Commercial real estate loans and advances including loan commitments by level of collateral

147

Other corporate, commercial and financial (non-bank)loans and advances including loan commitments by level of collateral rated CRR/EL8 to 10 only

148

Loans and advances to banks including loan commitmentsby level of collateral

149

Other credit risk exposures

149

Derivatives

149

Notional contract amounts and fair values of derivatives by product type

150

OTC collateral agreements by type

150

Reverse repos - non-trading by geographical region

151

Reverse repos - non-trading by geographical region

151

Loan Management Unit

213

 

Page

App

Tables

Page

Personal lending

151

Total personal lending

151

Mortgage lending

152

Other personal lending

153

HSBC Finance US Consumer and Mortgage Lending residential mortgages

153

HSBC Finance: foreclosed properties in the US

153

Trends in two months and over conctractual delinquency in the US

153

Gross loan portfolio of HSBC Finance and real estate secured balances

154

Number of renegotiated real estate secured accounts remaining in HSBC Finance's portfolio

154

HSBC Finance loan modifications and re-age programmes

154

Collateral and other credit enhancements held

156

Residential mortgage loans including loan commitments by level of collateral

156

Supplementary information

157

Gross loans and advances by industry sector over 5 years

157

Reconciliation of reported and constant currency impaired loans, allowances and charges by geographical region

158

Reconciliation of reported and constant currency loan impairment charges to the income statement

158

Loan impairment charges by industry sector over 5 years

159

Charge for impairment losses as a percentage of average gross loans and advances to customers

159

Movement in impairment allowances over 5 years

159

Gross loans and advances to customers by country

160

Refinance risk

214

HSBC Holdings

161

HSBC Holdings - maximum exposure to credit risk

161

Securitisation exposures and other structured products

161

214

Overall exposure of HSBC

161

Carrying amount of HSBC's consolidated holdings of ABSs

162

Definitions and classifications of ABSs and CDOs

214

Representations and warranties related to mortgage sales and securitisation activities

162

 

 

1 Appendix to Risk - risk policies and practices.

 

Credit risk

(Unaudited)

Credit risk is the risk of financial loss if a customer or counterparty fails to meet an obligation under a contract. It arises principally from direct lending, trade finance and leasing business, but also from other products such as guarantees and credit derivatives and from holding assets in the form of debt securities.

There were no material changes to our policies and practices for the management of credit risk in 2014.

A summary of our current policies and practices regarding credit risk is provided in the Appendix to Risk on page 204.

Our maximum exposure to credit risk is presented on page 131 and credit quality on page 133. While credit risk arises across most of our balance sheet, losses have typically been incurred on loans and advances and securitisation exposures and other structured products. As a result, our disclosures focus primarily on these two areas.

This year we have redesigned the 'Credit risk' section in order to enhance clarity and reduce duplication. It now begins with a summary of credit risk followed by an overview of our gross exposures. We describe various measures of credit quality such as past due status, impaired loans and renegotiated loans before analysing impairment allowances. There are specific sections on wholesale lending and personal lending where additional detail is provided and we cover areas of particular focus such as our exposure to commercial real estate in wholesale lending and our Consumer and Mortgage Lending ('CML') portfolio in personal lending. This is followed by a section describing our securitisation exposures and other structured products. Information on our exposures to oil and gas, Russia and Greece is provided in 'Areas of special interest' on page 126.

Following the change in balance sheet presentation explained on page 347, non-trading reverse repos are shown separately on the balance sheet and are no longer included in 'Loans and advances to customers' and 'Loans and advances to banks'. Comparative data have been re-presented accordingly. As a result, any analysis that references loans and advances to customers or banks excludes non-trading reverse repos. The amount of the non-trading reverse repos to customers and banks is set out on page 151.

Loan impairment charges, loan impairment allowances and impaired loans all reduced compared with 2013.

Gross loans and advances decreased by US$28bn which included adverse foreign exchange movements of US$51bn; excluding these movements customer lending grew in 2014.

The commentary that follows is on a constant currency basis, whilst tables are presented on a reported basis.

Summary of credit risk

(Unaudited)

2014

2013

Page

US$bn

US$bn

At year-end

Maximum exposure tocredit risk

3,133

3,112

131

Gross loans and advances1

- personal lending

393

411

132

- wholesale lending

706

716

132

Total

1,099

1,127

132

Impaired loans

- personal lending

15

19

137

- wholesale lending

14

18

137

Total

29

37

137

Impaired loans as a % ofgross loans and advances

- personal lending

3.9%

4.6%

- wholesale lending

2.0%

2.5%

- total

2.7%

3.3%

US$bn

US$bn

Impairment allowances

- personal lending

4.6

6.6

143

- wholesale lending

7.8

8.6

143

Total

12.4

15.2

143

Loans and advances net ofimpairment allowances1

1,087

1,112

For year ended 31 December

Loan impairment charge

- personal lending

1.8

3.1

141

- wholesale lending

2.3

2.9

141

Total

4.1

6.0

141

For footnote, see page 202.

See page 158 for further details in respect of the constant currency reconciliation. For an analysis of loans and advances by country see page 160.

Wholesale gross loans and advances increased by US$21bn. Asia grew by US$16bn and North America by US$10bn with more modest levels of growth in the Middle East and North Africa and Latin America. This was offset by a decrease of US$15bn in Europe. Loan impairment charges were lower in 2014 as we continued to benefit from the improvement in various economies and the low interest rate environment.

Personal lending balances, excluding the planned US CML portfolio run off, grew by US$7.7bn. This was primarily driven by increased mortgage and other lending in Asia and growth in the mortgage portfolio in both North America and Latin America. The growth was partially offset by lower lending balances in Europe due to repayments on the mortgage and credit card portfolio in the UK. The CML portfolio declined by a further US$5.7bn during the year. Loan impairment charges were down as a result of improvements in the US housing market and the continued run-off of the CML portfolio.

Gross loans to customers and banks over five years1(US$bn)

(Unaudited)

 

Loan impairment charge over five years (US$bn)

(Unaudited)

 

Loan impairment charges by geographical region (US$bn)

(Unaudited)

 

Loan impairment charges by industry (US$bn)

(Unaudited)

 

Loan impairment allowances over five years

(Unaudited)

 

For footnote, see page 202.

Credit exposure

Maximum exposure to credit risk

(Audited)

The table on page 131 provides information on balance sheet items, offsets and loan and other credit-related commitments. Commentary on balance sheet movements is provided on page 58. The offset on derivatives increased in line with the increase in maximum exposure amounts.

The offset on corporate and commercial loans to customers decreased by US$31bn. This reduction was in the UK where a small number of clients benefit from the use of net interest arrangements across their overdraft and deposit positions. During the year, as we aligned our approach in our Payments and Cash Management business to be more globally consistent, many of these clients increased the frequency with which they settled these balances thereby reducing the amount of offset available.

'Maximum exposure to credit risk' table (page 131)

The table presents our maximum exposure to credit risk from balance sheet and off‑balance sheet financial instruments before taking account of any collateral held or other credit enhancements (unless such enhancements meet accounting offsetting requirements). For financial assets recognised on the balance sheet, the maximum exposure to credit risk equals their carrying amount; for financial guarantees and similar contracts granted, it is the maximum amount that we would have to pay if the guarantees were called upon. For loan commitments and other credit-related commitments, it is generally the full amount of the committed facilities.

The offset in the table relates to amounts where there is a legally enforceable right of offset in the event of counterparty default and where, as a result, there is a net exposure for credit risk purposes. However, as there is no intention to settle these balances on a net basis under normal circumstances, they do not qualify for net presentation for accounting purposes.

In the case of derivatives the offset column also includes collateral received in cash and other financial assets.

Other credit risk mitigants

While not disclosed as an offset in the 'Maximum exposure to credit risk' table, other arrangements are in place which reduce our maximum exposure to credit risk. These include a charge over collateral over borrowers' specific assets such as residential properties. Other credit risk mitigants include short positions in securities and financial assets held as part of linked insurance/ investment contracts where the risk is predominantly borne by the policyholder. In addition, we hold collateral in the form of financial instruments that are not recognised on the balance sheet.

See Note 32 and from page 147 and page 156 respectively on the Financial Statements for further details on collateral in respect of certain loans and advances and derivatives.

Maximum exposure to credit risk

(Audited)

2014

2013

Maximumexposure

Offset

Net

Maximumexposure

Offset

Net

US$m

US$m

US$m

US$m

US$m

US$m

Cash and balances at central banks

129,957

-

129,957

166,599

-

166,599

Items in the course of collection from other banks

4,927

-

4,927

6,021

-

6,021

Hong Kong Government certificates of indebtedness

27,674

-

27,674

25,220

-

25,220

Trading assets

228,944

-

228,944

239,301

(1,777)

237,524

- Treasury and other eligible bills

16,170

-

16,170

21,584

-

21,584

- debt securities

141,532

-

141,532

141,644

-

141,644

- loans and advances to banks

27,581

-

27,581

27,885

-

27,885

- loans and advances to customers

43,661

-

43,661

48,188

(1,777)

46,411

Financial assets designated at fair value

9,031

-

9,031

12,719

-

12,719

- Treasury and other eligible bills

56

-

56

50

-

50

- debt securities

8,891

-

8,891

12,589

-

12,589

- loans and advances to banks

84

-

84

76

-

76

- loans and advances to customers

-

-

-

4

-

4

Derivatives

345,008

(313,300)

31,708

282,265

(252,344)

29,921

Loans and advances to customers held atamortised cost1

974,660

(67,094)

907,566

992,089

(96,726)

895,363

- personal

388,954

(4,412)

384,542

404,126

(1,348)

402,778

- corporate and commercial

535,184

(59,197)

475,987

537,922

(90,215)

447,707

- financial (non-bank financial institutions)

50,522

(3,485)

47,037

50,041

(5,163)

44,878

Loans and advances to banks held atamortised cost1

112,149

(258)

111,891

120,046

(587)

119,459

Reverse repurchase agreements - non-trading

161,713

(5,750)

155,963

179,690

(22,267)

157,423

Financial investments

404,773

-

404,773

416,785

-

416,785

- Treasury and other similar bills

81,517

-

81,517

78,111

-

78,111

- debt securities

323,256

-

323,256

338,674

-

338,674

Other assets

35,264

-

35,264

37,324

(22)

37,302

- assets held for sale

1,375

-

1,375

3,306

(22)

3,284

- endorsements and acceptances

10,775

-

10,775

11,624

-

11,624

- other

23,114

-

23,114

22,394

-

22,394

Financial guarantees and similar contracts2

47,078

-

47,078

46,300

-

46,300

Loan and other credit-related commitments3

651,380

-

651,380

587,603

-

587,603

At 31 December

3,132,558

(386,402)

2,746,156

3,111,962

(373,723)

2,738,239

For footnotes, see page 202.

Loan and other credit-related commitments3

(Unaudited)

Europe

Asia4

MENA

North

America

Latin

America

Total

US$m

US$m

US$m

US$m

US$m

US$m

Personal

86,247

96,497

2,995

15,636

11,679

213,054

Corporate and commercial

98,045

138,366

20,141

102,911

17,540

377,003

Financial5

26,605

9,355

711

23,559

1,093

61,323

At 31 December 2014

210,897

244,218

23,847

142,106

30,312

651,380

Personal

92,148

74,445

2,940

15,647

9,774

194,954

Corporate and commercial

91,895

120,084

19,045

92,837

21,956

345,817

Financial5

18,930

8,477

705

17,478

1,242

46,832

 

 

At 31 December 2013

202,973

203,006

22,690

125,962

32,972

587,603

For footnotes, see page 202.

Concentration of exposure

(Unaudited)

Concentrations of credit risk are described in the Appendix to Risk on page 206.

The geographical diversification of our lending portfolio and our broad range of global businesses and products ensured that we did not overly depend on a few markets to generate growth in 2014. This diversification also supported our strategy for growth in faster-growing markets and those with international connectivity.

Financial investments

Our holdings of available-for-sale government and government agency debt securities, corporate debt securities, ABSs and other securities were spread across a wide range of issuers and geographical regions in 2014, with 15% invested in securities issued by banks and other financial institutions and 72% in government or government agency debt securities. We also held assets backing insurance and investment contracts.

For an analysis of financial investments, see Note 18 on the Financial Statements.

Trading assets

Trading securities remained the largest concentration within trading assets at 77% compared with 75% in 2013. The largest concentration within the trading securitiesportfolio was in government and government agency debt securities. We had significant exposures to US Treasury and government agency debt securities (US$26bn) and UK (US$9.3bn) and Hong Kong (US$6.9bn) government debt securities.

For an analysis of debt and equity securities held for trading, see Note 12 on the Financial Statements.

Derivatives

Derivative assets were US$345bn at 31 December 2014 (2013: US$282bn). Details of derivative amounts cleared through an exchange, central counterparty and non-central counterparty are shown on page 150.

For an analysis of derivatives, see page 150 and Note 16 on the Financial Statements.

Loans and advances to customers

The following tables analyse loans and advances to customers by industry sector and by the location of the principal operations of the lending subsidiary or, in the case of the operations of The Hongkong and Shanghai Banking Corporation, HSBC Bank, HSBC Bank Middle East Limited ('HSBC Bank Middle East') and HSBC Bank USA, by the location of the lending branch. The distribution of loans across geographical regions and industries remained similar to last year.

For an analysis of loans and advances by country see page 160.

 

Gross loans and advances to customers by industry sector and by geographical region

(Audited)

Europe

Asia4

MENA

North America

Latin America

Total

As a %

of total

gross

US$m

US$m

US$m

US$m

US$m

US$m

loans

Personal

178,531

129,515

6,571

65,400

13,537

393,554

39.9

- first lien residential mortgages6

131,000

93,147

2,647

55,577

4,153

286,524

29.0

- other personal7

47,531

36,368

3,924

9,823

9,384

107,030

10.9

Corporate and commercial

210,585

220,799

20,588

57,862

30,722

540,556

54.8

- manufacturing

39,456

37,767

2,413

15,299

12,051

106,986

10.9

- international trade and services

76,629

72,814

9,675

13,484

8,189

180,791

18.3

- commercial real estate

28,187

35,678

579

6,558

2,291

73,293

7.4

- other property-related

7,126

34,379

1,667

8,934

281

52,387

5.3

- government

2,264

1,195

1,552

164

968

6,143

0.6

- other commercial8

56,923

38,966

4,702

13,423

6,942

120,956

12.3

Financial

23,103

13,997

3,291

9,034

1,393

50,818

5.1

- non-bank financial institutions

21,867

13,410

3,289

9,034

1,199

48,799

4.9

- settlement accounts

1,236

587

2

-

194

2,019

0.2

Asset-backed securities reclassified

1,938

-

-

131

-

2,069

0.2

Total gross loans and advances tocustomers at 31 December 2014 (A)

414,157

364,311

30,450

132,427

45,652

986,997

100.0

Percentage of A by geographical region

42.0%

36.9%

3.1%

13.4%

4.6%

100.0%

-

 

Europe

Asia4

MENA

North America

Latin America

Total

As a %

of total

gross

US$m

US$m

US$m

US$m

US$m

US$m

loans

Personal

192,107

124,529

6,484

72,690

14,918

410,728

40.8

- first lien residential mortgages6

140,474

92,047

2,451

60,955

3,948

299,875

29.8

- other personal7

51,633

32,482

4,033

11,735

10,970

110,853

11.0

Corporate and commercial

239,116

203,894

19,760

50,307

30,188

543,265

53.9

- manufacturing

55,920

30,758

3,180

11,778

12,214

113,850

11.3

- international trade and services

76,700

79,368

8,629

11,676

8,295

184,668

18.3

- commercial real estate

31,326

34,560

639

5,900

2,421

74,846

7.4

- other property-related

7,308

27,147

1,333

8,716

328

44,832

4.5

- government

3,340

1,021

1,443

499

974

7,277

0.7

- other commercial8

64,522

31,040

4,536

11,738

5,956

117,792

11.7

Financial

27,872

9,688

2,532

9,055

1,376

50,523

5.0

- non-bank financial institutions

26,314

9,359

2,532

9,055

1,277

48,537

4.8

- settlement accounts

1,558

329

-

-

99

1,986

0.2

Asset-backed securities reclassified

2,578

-

-

138

-

2,716

0.3

Total gross loans and advances tocustomers at 31 December 2013 (B)

461,673

338,111

28,776

132,190

46,482

1,007,232

100.0

Percentage of B by geographical region

45.8%

33.6%

2.9%

13.1%

4.6%

100.0%

For footnotes, see page 202.

Credit quality of financial instruments

(Audited)

A summary of our current policies and practices regarding the credit quality of financial instruments is provided in the Appendix to Risk on page 207.

We assess credit quality on all financial instruments which are subject to credit risk.

The five classifications describing the credit quality of our lending, debt securities portfolios and derivatives are defined on page 207 (unaudited). Additional credit quality information in respect of our consolidated holdings of ABSs is provided on page 162.

For the purpose of the following disclosure, retail loans which are past due up to 90 days and are not otherwise classified as impaired in accordance with our disclosure convention are not disclosed within the expected loss ('EL') grade to which they relate, but are separately classified as past due but not impaired.

The overall credit quality of assets remained stable with 'Strong' and 'Good' categories making up 84% of the portfolio, 'Satisfactory' 13%, 'Sub-standard' and 'Past due but not impaired' 2% and 'Impaired' 1%.

 

 

Distribution of financial instruments by credit quality

(Audited)

Neither past due nor impaired

Past due

but not

impaired

Total

gross

amount

Impairment

allowances9

Total

Strong

Good

Satisfactory

Sub-

standard

Impaired

 

 

 

US$m

 

US$m

 

US$m

 

US$m

US$m

 

US$m

 

US$m

 

US$m

 

US$m

Cash and balances at central banks

127,971

1,438

195

353

129,957

129,957

Items in the course of collection from other banks

4,515

46

365

1

4,927

4,927

Hong Kong Government certificates of indebtedness

27,674

-

-

-

27,674

27,674

Trading assets10

168,521

35,042

24,740

641

228,944

228,944

- treasury and other eligible bills

13,938

1,641

559

32

16,170

16,170

- debt securities

111,138

17,786

12,305

303

141,532

141,532

- loans and advances:

to banks

17,492

4,961

5,016

112

27,581

27,581

to customers

25,953

10,654

6,860

194

43,661

43,661

Financial assets designated atfair value10

3,017

4,476

1,207

331

9,031

9,031

- treasury and other eligible bills

5

-

-

51

56

56

- debt securities

3,011

4,476

1,124

280

8,891

8,891

- loans and advances:

to banks

1

-

83

-

84

84

to customers

-

-

-

-

-

-

Derivatives10

269,490

58,596

15,962

960

345,008

345,008

Loans and advances to customers held at amortised cost11

487,734

239,136

196,685

20,802

13,357

29,283

986,997

(12,337)

974,660

- personal

320,678

32,601

15,109

1,130

8,876

15,160

393,554

(4,600)

388,954

- corporate and commercial

141,375

192,799

171,748

18,986

3,922

13,795

542,625

(7,441)

535,184

- financial (non-bankfinancial institutions)

25,681

13,736

9,828

686

559

328

50,818

(296)

50,522

Loans and advances to banks held at amortised cost

83,766

19,525

7,945

914

1

47

112,198

(49)

112,149

Reverse repurchase agreements- non-trading

98,470

28,367

33,283

1,593

-

-

161,713

-

161,713

Financial investments

347,218

27,373

22,600

5,304

-

2,278

404,773

404,773

- treasury and other similar bills

68,966

6,294

4,431

1,826

-

-

81,517

81,517

- debt securities

278,252

21,079

18,169

3,478

-

2,278

323,256

323,256

Other assets

13,015

7,564

12,976

631

210

884

35,280

(16)

35,264

- assets held for sale

802

43

79

-

2

465

1,391

(16)

1,375

- endorsements and acceptances

1,507

4,644

4,281

298

34

11

10,775

10,775

- accrued income and other

10,706

2,877

8,616

333

174

408

23,114

23,114

At 31 December 2014

1,631,391

421,563

315,958

31,530

13,568

32,492

2,446,502

(12,402)

2,434,100

 

Neither past due nor impaired

Past due

Total

gross

amount

Strong

Good

Satisfactory

Sub-

standard

but not

impaired

Impaired

Impairment

allowances9

Total

US$m

US$m

US$m

US$m

US$m

US$m

US$m

US$m

US$m

Cash and balances at central banks

162,017

2,877

265

1,440

166,599

166,599

Items in the course of collection from other banks

5,590

66

286

79

6,021

6,021

Hong Kong Government certificates of indebtedness

25,220

-

-

-

25,220

25,220

Trading assets10

163,444

39,475

34,868

1,514

239,301

239,301

- treasury and other eligible bills

17,235

3,585

758

6

21,584

21,584

- debt securities

107,831

16,498

16,167

1,148

141,644

141,644

- loans and advances:

to banks

15,804

5,546

6,342

193

27,885

27,885

to customers

22,574

13,846

11,601

167

48,188

48,188

Financial assets designated atfair value10

6,608

5,183

671

257

12,719

12,719

- treasury and other eligible bills

50

-

-

-

50

50

- debt securities

6,490

5,179

664

256

12,589

12,589

- loans and advances:

to banks

68

-

7

1

76

76

to customers

-

4

-

-

4

4

Derivatives10

220,711

47,004

13,425

1,125

282,265

282,265

Loans and advances to customers held at amortised cost11

488,504

243,077

199,821

23,942

15,460

36,428

1,007,232

(15,143)

992,089

- personal

326,269

39,024

14,882

1,580

10,175

18,798

410,728

(6,602)

404,126

- corporate and commercial

132,943

194,966

174,905

21,281

5,009

16,877

545,981

(8,059)

537,922

- financial (non-bankfinancial institutions)

29,292

9,087

10,034

1,081

276

753

50,523

(482)

50,041

Loans and advances to banks held at amortised cost

91,498

21,131

6,266

1,123

11

75

120,104

(58)

120,046

Reverse repurchase agreements- non-trading

111,543

37,878

28,265

2,004

-

-

179,690

-

179,690

Financial investments

362,799

27,833

17,556

6,089

-

2,508

416,785

416,785

- treasury and other similar bills

69,364

5,595

1,856

1,296

-

-

78,111

78,111

- debt securities

293,435

22,238

15,700

4,793

-

2,508

338,674

338,674

Other assets

12,501

8,028

14,848

1,159

307

592

37,435

(111)

37,324

- assets held for sale

1,129

642

1,050

351

89

156

3,417

(111)

3,306

- endorsements and acceptances

1,976

4,824

4,562

225

19

18

11,624

11,624

- accrued income and other

9,396

2,562

9,236

583

199

418

22,394

22,394

At 31 December 2013

1,650,435

432,552

316,271

38,732

15,778

39,603

2,493,371

(15,312)

2,478,059

For footnotes, see page 202.

Past due but not impaired gross financial instruments

(Audited)

Past due but not impaired gross financial instruments are those loans where, although customers have failed to make payments in accordance with the contractual terms of their facilities, they have not met the impaired loan criteria described on page 137.

Overall, past due but not impaired balances decreased by US$2.2bn, mainly due to continued run-off and loan sales in the CML portfolio.

 

Past due but not impaired gross financial instruments by geographical region

(Audited)

Europe

Asia4

MENA

North America

Latin America

Total

US$m

US$m

US$m

US$m

US$m

US$m

Loans and advances to customers held atamortised cost

2,409

4,260

704

4,634

1,350

13,357

- personal

1,159

2,880

182

3,759

896

8,876

- corporate and commercial

1,244

1,102

508

623

445

3,922

- financial (non-bank financial institutions)

6

278

14

252

9

559

Other financial instruments

6

52

31

97

25

211

At 31 December 2014

2,415

4,312

735

4,731

1,375

13,568

Loans and advances to customers held atamortised cost

2,399

4,211

757

6,453

1,640

15,460

- personal

1,287

2,764

174

4,817

1,133

10,175

- corporate and commercial

1,092

1,197

580

1,635

505

5,009

- financial (non-bank financial institutions)

20

250

3

1

2

276

Other financial instruments

45

49

50

101

73

318

At 31 December 2013

2,444

4,260

807

6,554

1,713

15,778

For footnote, see page 202.

Ageing analysis of days for past due but not impaired gross financial instruments

(Audited)

Up to 29 days

30-59days

60-89days

90-179 days

180 days

and over

Total

US$m

US$m

US$m

US$m

US$m

US$m

Loans and advances to customers held at amortised cost

10,427

2,057

801

54

18

13,357

- personal

6,477

1,717

676

5

1

8,876

- corporate and commercial

3,417

328

114

48

15

3,922

- financial (non-bank financial institutions)

533

12

11

1

2

559

Other financial instruments

130

33

18

12

18

211

At 31 December 2014

10,557

2,090

819

66

36

13,568

Loans and advances to customers held at amortised cost

11,689

2,587

1,057

76

51

15,460

- personal

7,170

2,124

865

16

-

10,175

- corporate and commercial

4,290

418

190

60

51

5,009

- financial (non-bank financial institutions)

229

45

2

-

-

276

Other financial instruments

214

55

26

12

11

318

At 31 December 2013

11,903

2,642

1,083

88

62

15,778

 

 

Impaired loans

(Audited)

Impaired loans and advances are those that meet any of the following criteria:

· wholesale loans and advances classified as Customer Risk Rating ('CRR') 9 or CRR 10. These grades are assigned when the bank considers that either the customer is unlikely to pay their credit obligations in full, without recourse to security, or when the customer is more than 90 days past due on any material credit obligation to HSBC.

· retail loans and advances classified as Expected Loss ('EL') 9 or EL 10. These grades are typically assigned to retail loans and advances more than 90 days past due unless individually they have been assessed as not impaired.

· renegotiated loans and advances that have been subject to a change in contractual cash flows as a result of a concession which the lender would not otherwise consider, and where it is probable that without the concession the borrower would be unable to meet the contractual payment obligations in full, unless the concession is insignificant and there are no other indicators of impairment. Renegotiated loans remain classified as impaired until there is sufficient evidence to demonstrate a significant reduction in the risk of non-payment of future cash flows, and there are no other indicators of impairment.

For loans that are assessed for impairment on a collective basis, the evidence to support reclassification as no longer impaired typically comprises a history of payment performance against the original or revised terms, depending on the nature and volume of renegotiation and the credit risk characteristics surrounding the renegotiation. For loans that are assessed for impairment on an individual basis, all available evidence is assessed on a case-by-case basis.

For further details of the CRR and the EL scales see page 207.

 

Movement in impaired loans by geographical region

(Unaudited)

Europe

Asia4

MENA

North America

Latin

America

Total

US$m

US$m

US$m

US$m

US$m

US$m

Impaired loans at 1 January 2014

13,228

1,623

2,285

15,123

4,244

36,503

- personal

2,938

526

317

13,669

1,348

18,798

- corporate and commercial

9,714

1,082

1,765

1,427

2,889

16,877

- financial5

576

15

203

27

7

828

Classified as impaired during the year

3,367

1,970

346

4,724

3,342

13,749

- personal

1,168

857

193

4,360

1,958

8,536

- corporate and commercial

2,166

1,113

153

354

1,383

5,169

- financial5

33

-

-

10

1

44

Transferred from impaired to unimpaired duringthe year

(1,661)

(230)

(320)

(2,609)

(730)

(5,550)

- personal

(282)

(184)

(178)

(2,551)

(364)

(3,559)

- corporate and commercial

(1,319)

(46)

(53)

(57)

(366)

(1,841)

- financial5

(60)

-

(89)

(1)

-

(150)

Amounts written off

(2,037)

(617)

(111)

(1,369)

(2,048)

(6,182)

- personal

(631)

(470)

(77)

(1,007)

(1,371)

(3,556)

- corporate and commercial

(1,201)

(147)

(29)

(356)

(673)

(2,406)

- financial5

(205)

-

(5)

(6)

(4)

(220)

Net repayments and other

(2,655)

(698)

(219)

(4,175)

(1,443)

(9,190)

- personal

(649)

(238)

(13)

(3,645)

(514)

(5,059)

- corporate and commercial

(1,975)

(457)

(140)

(506)

(926)

(4,004)

- financial5

(31)

(3)

(66)

(24)

(3)

(127)

Impaired loans at 31 December 2014

10,242

2,048

1,981

11,694

3,365

29,330

- personal

2,544

491

242

10,826

1,057

15,160

- corporate and commercial

7,385

1,545

1,696

862

2,307

13,795

- financial5

313

12

43

6

1

375

Impaired loans as a percentage of gross loans

%

2.3%

0.5%

4.8%

8.4%

6.1%

2.7%

- personal

1.4%

0.4%

3.7%

16.6%

7.8%

3.9%

- corporate and commercial

3.5%

0.7%

8.2%

1.5%

7.5%

2.5%

- financial5

0.7%

0.0%

0.3%

0.0%

0.0%

0.2%

 

Movement in impaired loans by geographical region (continued)

(Unaudited)

Europe

Asia4

MENA

North America

Latin

America

Total

US$m

US$m

US$m

US$m

US$m

US$m

Impaired loans at 1 January 2013

11,145

1,624

2,474

20,345

3,188

38,776

- personal

2,466

611

368

18,726

1,580

23,751

- corporate and commercial

8,058

967

1,872

1,592

1,604

14,093

- financial5

621

46

234

27

4

932

Classified as impaired during the year

4,952

1,424

419

6,168

4,333

17,296

- personal

1,176

798

107

5,319

1,872

9,272

- corporate and commercial

3,726

623

306

837

2,453

7,945

- financial5

50

3

6

12

8

79

Transferred from impaired to unimpaired duringthe year

(1,215)

(145)

(166)

(3,198)

(642)

(5,366)

- personal

(265)

(137)

(68)

(3,172)

(266)

(3,908)

- corporate and commercial

(804)

(8)

(85)

(24)

(375)

(1,296)

- financial5

(146)

-

(13)

(2)

(1)

(162)

Amounts written off

(1,411)

(538)

(165)

(1,706)

(1,957)

(5,777)

- personal

(423)

(444)

(79)

(1,433)

(1,456)

(3,835)

- corporate and commercial

(927)

(91)

(75)

(270)

(499)

(1,862)

- financial5

(61)

(3)

(11)

(3)

(2)

(80)

Net repayments and other

(243)

(742)

(277)

(6,486)

(678)

(8,426)

- personal

(16)

(302)

(11)

(5,771)

(382)

(6,482)

- corporate and commercial

(339)

(409)

(253)

(708)

(294)

(2,003)

- financial5

112

(31)

(13)

(7)

(2)

59

Impaired loans at 31 December 2013

13,228

1,623

2,285

15,123

4,244

36,503

- personal

2,938

526

317

13,669

1,348

18,798

- corporate and commercial

9,714

1,082

1,765

1,427

2,889

16,877

- financial5

576

15

203

27

7

828

Impaired loans as a percentage of gross loans

2.7%

0.4%

6.5%

10.9%

7.5%

3.2%

- personal

1.5%

0.4%

4.9%

18.8%

9.0%

4.6%

- corporate and commercial

4.0%

0.5%

8.9%

2.8%

9.6%

3.1%

- financial5

1.1%

0.0%

2.3%

0.2%

0.1%

0.5%

For footnotes, see page 202.

Impaired loans decreased by US$7.2bn during the year. Personal impaired loans declined mainly due to the continued run off and loan sales in the CML portfolio in North America. In personal lending, 'Net repayments and other' includes US$2.9bn of CML portfolio assets that were reclassified as held for sale and also sold during the year.

Impaired loans in wholesale lending declined mainly in Europe and, to a lesser extent, in North America and Latin America due to repayments and a reduction in new impaired loans which reflected improvements in the economic conditions in these markets. These decreases were offset by an increase in Asia.

Renegotiated loans and forbearance

(Audited)

Current policies and procedures regarding renegotiated loans and forbearance are described in the Appendix to Risk on page 208.

The contractual terms of a loan may be modified for a number of reasons, including changes in market conditions, customer retention and other factors not related to the current or potential credit deterioration of a customer. 'Forbearance' describes concessions made on the contractual terms of a loan in response to an obligor's financial difficulties. We classify and report loans on which concessions have been granted under conditions of credit distress as 'renegotiated loans' when their contractual payment terms have been modified, because we have significant concerns about the borrowers' ability to meet contractual payments when due. On renegotiation, where the existing agreement is cancelled and a new agreement is made on substantially different terms, or if the terms of an existing agreement are modified such that the renegotiated loan is substantially a different financial instrument, the loan would be derecognised and recognised as a new loan for accounting purposes. However, the newly recognised financial asset will retain the renegotiated loan classification. Concessions on loans made to customers which do not affect the payment structure or basis of repayment, such as waivers of financial or security covenants, do not directly provide concessionary relief to customers in terms of their ability to service obligations as they fall due and are therefore not included in this classification.

The most significant portfolio of renegotiated loans remained in North America, substantially all of which were retail loans held by HSBC Finance.

The following tables show the gross carrying amounts of the Group's holdings of renegotiated loans and advances to customers by industry sector, geography and credit quality classification.

Renegotiated loans and advances to customers by geographical region

(Audited)

Europe

Asia4

MENA

North America

Latin America

Total

US$m

US$m

US$m

US$m

US$m

US$m

First lien residential mortgages

1,605

94

58

13,540

60

15,357

- neither past due nor impaired

529

63

19

3,695

32

4,338

- past due but not impaired

221

8

1

1,894

5

2,129

- impaired

855

23

38

7,951

23

8,890

Other personal lending7

324

292

27

1,267

326

2,236

- neither past due nor impaired

184

173

16

453

14

840

- past due but not impaired

40

22

5

214

1

282

- impaired

100

97

6

600

311

1,114

Corporate and commercial

5,469

501

1,439

427

1,324

9,160

- neither past due nor impaired

1,383

102

483

36

303

2,307

- past due but not impaired

68

-

31

1

1

101

- impaired

4,018

399

925

390

1,020

6,752

Financial5

413

4

323

1

1

742

- neither past due nor impaired

219

-

305

-

-

524

- past due but not impaired

-

-

-

-

-

-

- impaired

194

4

18

1

1

218

Renegotiated loans at 31 December 2014

7,811

891

1,847

15,235

1,711

27,495

- neither past due nor impaired

2,315

338

823

4,184

349

8,009

- past due but not impaired

329

30

37

2,109

7

2,512

- impaired

5,167

523

987

8,942

1,355

16,974

Impairment allowances on renegotiated loans

1,458

170

458

1,499

704

4,289

- renegotiated loans as % of total gross loans

1.9%

0.2%

6.1%

11.5%

3.7%

2.8%

First lien residential mortgages

1,820

117

91

16,853

76

18,957

- neither past due nor impaired

392

78

47

4,332

32

4,881

- past due but not impaired

517

11

3

2,684

4

3,219

- impaired

911

28

41

9,837

40

10,857

Other personal lending7

431

318

58

1,277

531

2,615

- neither past due nor impaired

253

207

33

503

18

1,014

- past due but not impaired

39

24

17

284

2

366

- impaired

139

87

8

490

511

1,235

Corporate and commercial

7,270

330

1,583

658

2,161

12,002

- neither past due nor impaired

1,796

134

677

47

493

3,147

- past due but not impaired

193

4

126

34

5

362

- impaired

5,281

192

780

577

1,663

8,493

Financial5

235

2

362

1

1

601

- neither past due nor impaired

93

-

265

-

-

358

- past due but not impaired

-

-

-

-

-

-

- impaired

142

2

97

1

1

243

Renegotiated loans at 31 December 2013

9,756

767

2,094

18,789

2,769

34,175

- neither past due nor impaired

2,534

419

1,022

4,882

543

9,400

- past due but not impaired

749

39

146

3,002

11

3,947

- impaired

6,473

309

926

10,905

2,215

20,828

Impairment allowances on renegotiated loans

1,867

101

460

2,285

1,014

5,727

- renegotiated loans as % of total gross loans

2.1%

0.2%

7.3%

14.2%

6.0%

3.4%

For footnotes, see page 202.

The following table shows movements in renegotiated loans during the year. Renegotiated loans reduced by US$6.7bn to US$27bn in 2014. Renegotiated loans in personal lending reduced by US$4bn. Included within 'other' movements is US$1.9bn of CML portfolio assets that were transferred to held for sale. New renegotiated loans and write-offs reduced as a result of improvements in the US housing market and economic conditions.

Renegotiated loans in wholesale lending decreased by US$2.7bn. The reductions were mainly concentrated in Europe and Latin America and were the result of increased write-offs and repayments.

 

Movement in renegotiated loans by geographical region

(Unaudited)

Europe

Asia4

MENA

North America

Latin America

Total

US$m

US$m

US$m

US$m

US$m

US$m

Renegotiated loans at 1 January 2014

9,756

767

2,094

18,789

2,769

34,175

- personal

2,251

435

149

18,130

607

21,572

- corporate and commercial

7,270

330

1,583

658

2,161

12,002

- financial

235

2

362

1

1

601

Loans renegotiated in the year without derecognition

1,543

371

296

862

725

3,797

- personal

433

83

10

774

310

1,610

- corporate and commercial

939

288

286

78

415

2,006

- financial

171

-

-

10

-

181

Loans renegotiated in the year resulting in recognition of a new loan

500

5

79

-

92

676

- personal

69

2

-

-

28

99

- corporate and commercial

381

-

61

-

64

506

- financial

50

3

18

-

-

71

Repayments

(2,416)

(246)

(562)

(1,518)

(1,036)

(5,778)

- personal

(635)

(96)

(47)

(1,319)

(288)

(2,385)

- corporate and commercial

(1,757)

(149)

(445)

(189)

(747)

(3,287)

- financial

(24)

(1)

(70)

(10)

(1)

(106)

Amounts written off

(828)

(42)

(23)

(640)

(510)

(2,043)

- personal

(88)

(28)

(7)

(568)

(223)

(914)

- corporate and commercial

(740)

(14)

(16)

(72)

(286)

(1,128)

- financial

-

-

-

-

(1)

(1)

Other

(744)

36

(37)

(2,258)

(329)

(3,332)

- personal

(101)

(10)

(20)

(2,210)

(48)

(2,389)

- corporate and commercial

(624)

46

(30)

(48)

(283)

(939)

- financial

(19)

-

13

-

2

(4)

At 31 December 2014

7,811

891

1,847

15,235

1,711

27,495

- personal

1,929

386

85

14,807

386

17,593

- corporate and commercial

5,469

501

1,439

427

1,324

9,160

- financial

413

4

323

1

1

742

Renegotiated loans at 1 January 2013

9,974

944

2,389

26,162

2,758

42,227

- personal

2,817

493

190

25,474

781

29,755

- corporate and commercial

6,829

447

1,859

685

1,975

11,795

- financial

328

4

340

3

2

677

Loans renegotiated in the year without derecognition

2,807

49

101

1,727

1,311

5,995

- personal

264

8

16

1,335

507

2,130

- corporate and commercial

2,541

41

85

391

803

3,861

- financial

2

-

-

1

1

4

Loans renegotiated in the year resulting in recognition of a new loan

105

113

14

-

62

294

- personal

17

76

14

-

25

132

- corporate and commercial

88

37

-

-

37

162

- financial

-

-

-

-

-

-

Repayments

(2,139)

(233)

(541)

(1,759)

(707)

(5,379)

- personal

(489)

(111)

(64)

(1,387)

(353)

(2,404)

- corporate and commercial

(1,574)

(121)

(477)

(370)

(354)

(2,896)

- financial

(76)

(1)

-

(2)

-

(79)

Amounts written off

(426)

(25)

(38)

(1,035)

(409)

(1,933)

- personal

(99)

(20)

(9)

(995)

(233)

(1,356)

- corporate and commercial

(303)

(5)

(29)

(40)

(175)

(552)

- financial

(24)

-

-

-

(1)

(25)

Other

(565)

(81)

169

(6,306)

(246)

(7,029)

- personal

(259)

(11)

2

(6,297)

(120)

(6,685)

- corporate and commercial

(311)

(69)

145

(8)

(125)

(368)

- financial

5

(1)

22

(1)

(1)

24

At 31 December 2013

9,756

767

2,094

18,789

2,769

34,175

- personal

2,251

435

149

18,130

607

21,572

- corporate and commercial

7,270

330

1,583

658

2,161

12,002

- financial

235

2

362

1

1

601

For footnote, see page 202.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSUROSRVUAOUAR
Date   Source Headline
17th Jun 20245:39 pmRNSTransaction in Own Shares
14th Jun 20245:20 pmRNSTransaction in Own Shares
14th Jun 202411:00 amRNSIssuance of contingent convertible securities
13th Jun 20245:30 pmRNSTransaction in Own Shares
13th Jun 20247:00 amRNSIssuance of contingent convertible securities
12th Jun 20245:24 pmRNSTransaction in Own Shares
11th Jun 20245:38 pmRNSTransaction in Own Shares
11th Jun 20241:00 pmRNSFirst Interim and Special Dividend - Exchange Rate
10th Jun 20245:15 pmRNSTransaction in Own Shares
7th Jun 20245:32 pmRNSTransaction in Own Shares
6th Jun 20245:16 pmRNSTransaction in Own Shares
5th Jun 20245:44 pmRNSTransaction in Own Shares
4th Jun 20245:22 pmRNSTransaction in Own Shares
3rd Jun 20245:12 pmRNSTransaction in Own Shares
31st May 20245:23 pmRNSTransaction in Own Shares
31st May 20244:30 pmRNSTotal Voting Rights
30th May 20245:28 pmRNSTransaction in Own Shares
29th May 20245:28 pmRNSTransaction in Own Shares
29th May 20244:30 pmRNSDirector/PDMR Shareholding
28th May 20245:27 pmRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20245:38 pmRNSTransaction in Own Shares
23rd May 20245:30 pmRNSTransaction in Own Shares
22nd May 20245:23 pmRNSTransaction in Own Shares
21st May 20245:25 pmRNSTransaction in Own Shares
20th May 20245:34 pmRNSTransaction in Own Shares
20th May 20243:06 pmRNSIssuance of senior unsecured notes
17th May 20245:32 pmRNSTransaction in Own Shares
17th May 20242:30 pmRNSIssuance of senior unsecured notes
16th May 20245:23 pmRNSTransaction in Own Shares
15th May 20245:40 pmRNSTransaction in Own Shares
15th May 202411:00 amRNSResults of tender offers for four series of notes
14th May 20245:55 pmRNSPricing terms for tender offers for notes
14th May 20245:54 pmRNSTransaction in Own Shares
14th May 20248:52 amRNSHolding(s) in Company
13th May 20245:30 pmRNSTransaction in Own Shares
13th May 20249:23 amRNSHolding(s) in Company
13th May 20249:16 amRNSPre Stabilisation Notice
10th May 20245:28 pmRNSTransaction in Own Shares
10th May 202410:01 amRNSDirector/PDMR Shareholding
10th May 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
10th May 20249:03 amRNSHolding(s) in Company
9th May 20245:36 pmRNSTransaction in Own Shares
8th May 20245:40 pmRNSTransaction in Own Shares
8th May 20247:00 amRNSHSBC tender offers for four series of notes
7th May 202410:30 amRNSHSBC Holdings plc – Share buy-back
3rd May 20243:20 pmRNSAGM poll results + changes Board+Ctte composition
3rd May 202411:06 amRNSHSBC Holdings plc - AGM Statements
1st May 20244:30 pmRNSDirector Declaration
1st May 20244:00 pmRNSPublication of base prospectus supplement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.